Fibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) Genetics Investing
Abeona Therapeutics to Present at Gene, Cell and Molecular Therapies for Inherited Metabolic Diseases Meeting Genetics Investing
Transgenomic to Hold Full Year Financial Results Conference Call on April 14, 2016 at 5:00 PM ET Genetics Investing
Arrowhead Pharmaceuticals Presents Promising ARC-520 Hepatitis B Data at The International Liver Congress™ 2016 Genetics Investing
Inova Translational Medicine Institute Partners with Translational Software on MediMap™, an Optional Newborn Pharmacogenomic Test at Inova Women’s Hospital Genetics Investing
Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A) as a Valuable Tool in Identifying Viable Embryos During In Vitro Fertilization (IVF) Genetics Investing
GE Ventures and Mayo Clinic Launch Company to Scale and Digitize Cell and Gene Therapies Genetics Investing
Galapagos Initiates a Phase 2a Study with GLPG1690 in Idiopathic Pulmonary Fibrosis Patients Biotech Investing